Skip to content

Vicor Pacer Model 410A

by Tpl-Cordis, Inc.

510(k) K880432

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK880432 Date22 Feb 1988ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Vicor Pacer Model 410A is an implantable pacemaker pulse-generator, designed to regulate heart rhythm by delivering electrical impulses to the heart muscle when needed. It is classified as a Class III medical device under FDA regulations, requiring a Premarket Approval (PMA) or 510(k) clearance for market authorization. This device is intended for patients with bradycardia or other cardiac conduction disorders requiring artificial pacing.

The Vicor Pacer Model 410A is implanted subcutaneously in the chest, typically near the collarbone, and connected to leads placed within the heart chambers. It is a reusable device, intended for long-term use, and must be handled under sterile conditions during implantation. The device operates within MRI-safe parameters as defined by its specifications, though specific MRI compatibility should be confirmed with the manufacturer. Authorized for use in the United States under FDA 510(k) clearance (K880432), it adheres to regulatory standards outlined in 21 CFR 870.3610 for implantable pacemakers.

Other devices from Tpl-Cordis, Inc.

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of patients is the Vicor Pacer Model 410A intended to treat, and how does it work?

    The Vicor Pacer Model 410A is designed for patients with bradycardia or other cardiac conduction disorders that require artificial pacing. It regulates heart rhythm by delivering electrical impulses to the heart muscle when the natural heartbeat is too slow or irregular. The device is implanted subcutaneously in the chest and connected to leads placed within the heart chambers to ensure proper pacing.

  • Is the Vicor Pacer Model 410A a single-use or reusable device, and what are the handling requirements during implantation?

    The Vicor Pacer Model 410A is a reusable device intended for long-term use. Since it is implanted subcutaneously, it must be handled under sterile conditions during the implantation procedure to prevent infection and ensure patient safety.

  • Can this device be used safely in an MRI environment, and what should clinicians confirm before proceeding?

    The Vicor Pacer Model 410A operates within MRI-safe parameters as defined by its specifications. However, clinicians should confirm specific MRI compatibility details with the manufacturer before any MRI procedure, as individual patient cases and settings may vary.

  • What regulatory pathway was followed for market authorization of the Vicor Pacer Model 410A in the United States?

    The Vicor Pacer Model 410A was authorized for use in the United States through an FDA 510(k) clearance process, specifically under clearance number K880432. This device falls under Class III regulatory classification, requiring a Premarket Approval (PMA) or 510(k) clearance for market authorization.